Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The U.K. Bans Microbeads

If you’ve ever exfoliated your skin or brushed your teeth with toothpaste, you’ve probably used a microbead. Microbeads are the tiny plastic spheres found in many exfoliating facial scrubs, shower gels, toothpastes and other rinse-off skincare products on the market. They are in the class of microplastics, pieces of plastic less than five millimeters, or…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

If you’ve ever exfoliated your skin or brushed your teeth with toothpaste, you’ve probably used a microbead. Microbeads are the tiny plastic spheres found in many exfoliating facial scrubs, shower gels, toothpastes and other rinse-off skincare products on the market. They are in the class of microplastics, pieces of plastic less than five millimeters, or 0.2-inches, long. Found in chewing gum, glitter, industrial cleaning products, synthetic clothing fibers and even tires, microplastics are everywhere, and that’s a big problem for the world’s oceans.

Because they’re so small, microbeads cannot be filtered out by wastewater treatment plants and end up in the watershed. From there, they are inadvertently eaten by fish and other marine animals—the very fish and marine animals that are an important part of the food chain. This means humans ultimately end up eating the very plastic they were using to wash their faces. This can cause hormone disruptions and cancer. In response to health concerns, the U.K. government pledged to ban the manufacturing of cosmetic products containing microbeads in 2016. The ban just took effect on January 8, 2018 and joins similar bans enacted by the U.S., Canada, and New Zealand.

While this move is certainly a positive for the world’s ocean ecosystems and our own food chain, plastic in its many forms remains a problem for the environment, for ocean animals, and for our own health. Some municipalities are looking to tax or ban plastic grocery bags or plastic-coated cups, and leaders are calling for a reduction in the use of bottled water packaged in plastic.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Healthcare digital transformation stalls when teams stay disconnected

Healthcare digital transformation stalls when teams stay disconnected

Despite over 70% of healthcare executives prioritizing digital transformation, fragmented communication and information silos are hindering progress. Effective teamwork and integration are critical for achieving these goals. Bridging these gaps could enhance results in the healthcare industry's digital initiatives.

  • 01Over 70% of healthcare executives prioritize digital transformation.
  • 02Fragmented communication and information silos limit progress.
  • 03Effective integration is crucial for successful digital initiatives.

Jul 15, 2026

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The article discusses the advancements in healthcare with a focus on virtual care, AI, and access, featuring insights from Dr. Geoffrey Rutledge. It explores how these technologies are shaping the future of healthcare delivery. The conversation touches upon the impact on patient care and the potential for improved healthcare accessibility.

  • 01Virtual care and AI are transforming healthcare.
  • 02These technologies enhance patient accessibility and care.
  • 03Healthcare delivery is continuously evolving with new innovations.

Jul 14, 2026

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512